MITF as a driver oncogene and therapeutic target in angiomyolipoma/LAM

Awardee: David Kwiatkowski

Institution: Brigham and Women's Hospital

Award Amount: $50,500

Funding Period: January 1, 2016 - December 31, 2016

Previous
Previous

Characterization of NPC1-I1061T proteostasis machinery for development of NPC therapeutics

Next
Next

Patient-Derived Phenotypic Assay to Discover Treatments for Tay-Sachs Disease